Home > Healthcare > Medical Devices > Diagnostic Devices > Rabies Diagnostics Market

Rabies Diagnostics Market Trends

Report ID: GMI10186
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Rabies Diagnostics Market Trends

Recent technological advancements in rabies diagnostics are significantly driving market growth. The combination of AI, point-of-care testing, and advanced molecular techniques represents a significant leap forward in the fight against rabies.

AI-driven tools can quickly analyze and interpret complex data from various diagnostic tests, reducing the likelihood of human error and ensuring rapid, precise detection of the rabies virus.
Also, the development of point-of-care testing devices which allow for immediate, on-site diagnosis of rabies are gaining momentum. These portable diagnostic tools are particularly valuable in remote or resource-limited settings, where access to traditional laboratory facilities is often limited.
Additionally, innovations in molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), have greatly improved the sensitivity and specificity of rabies detection, further enhancing the ability to accurately diagnose the disease at earlier stages?.
These technological advancements are not only improving diagnostic capabilities but also fostering market growth by meeting the rising demand for efficient and reliable rabies diagnostics solutions.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Rabies diagnostics industry size was USD 1.8 billion in 2023 and is projected to expand at 4.7% CAGR from 2024 to 2032, due to the rising cases of animal bites, coupled with favorable government policies.

The fluorescent antibody test (FAT) segment in the rabies diagnostics industry accounted for USD 503.1 million in 2023 and is estimated to grow at significant CAGR from 2024 to 2032, owing to its reliability, accuracy, and long history of use.

The ELISA technology segment in the rabies diagnostics industry is projected to record USD 911.3 million by 2032, due to their high sensitivity and specificity in detecting antibodies or antigens related to the rabies virus.

North America rabies diagnostics industry amassed USD 765.8 million in revenue in 2023 and is projected to depict substantial gains from 2024 to 2032, led by the growing prevalence of rabies in the region.